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Abstract
Purpose—To assess interobserver variability of R.E.N.A.L., PADUA, and C-Index systems 
among observers with varying degrees of clinical experience and each system's subscale 
correlation with surgical outcome metrics.
Methods—Computed tomography images of 90 patients who underwent open, laparoscopic, or 
robot-assisted laparoscopic partial nephrectomy were scored by 1 radiology fellow, 2 urology 
fellows, 1 radiology resident, and 1 secondary school student. Agreement among readers was 
determined calculating intraclass correlation coefficients. Associations between radiology fellow 
scores (reference standard as reader with greatest clinical experience), ischemia time, and percent 
change in postoperative eGFR were evaluated using Spearman correlation.
Results—Agreement using C-Index method (ICC = 0.773) was higher than with PADUA (ICC = 
0.677) or R.E.N.A.L (ICC = 0.660). Agreement between reference and secondary school student 
was lower than with other physicians, although the differences were not statistically significant. 
The reference's scores were significantly (p <0.05) associated with ischemia time on all three 
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scoring systems and with percent change in eGFR at 6 weeks using C-index (p = 0.016). Tumor 
size, nearness to sinus, location relative to polar lines (R.E.N.A.L.) and tumor size, renal sinus 
involvement and collecting system involvement (PADUA) correlated with ischemia time (all p 
≤0.001). No R.E.N.A.L. or PADUA subscales significantly correlated with percent change in 
postoperative eGFR.
Conclusions—Clinical experience reduces interobserver variability of existing nephrometry 
systems though not significantly and less so when using directly measureable anatomic variables. 
Consistently, only measures of tumor size and distance to intrarenal structures were useful in 
predicting clinically relevant outcomes.
Keywords
kidney neoplasms; nephrometry; observer variability; partial nephrectomy; outcome assessment
Introduction
Comparisons of technical aspects and oncologic outcomes among management options for 
clinically localized renal masses [1] are often confounded by factors difficult to control for, 
particularly in characterizing the tumor with biometric data from imaging studies. Such 
information is crucial for evaluating disease management and disease-related outcomes.
Description of anatomic characteristics of renal masses using one of the recently introduced 
nephrometry scoring systems [2-4] allows for comparisons between reported experiences 
and has become almost a standard requirement for clinical studies on renal tumors. 
Nephrometry has been also increasingly incorporated into clinical practice [5] due to its 
potential usefulness in understanding the complexity of partial nephrectomy (PN) and the 
severity and aggressiveness of kidney cancer [6-8]. Though many systems have been 
devised, there is no current standard and the systems are not interchangeable or translatable 
creating obvious difficulties with reporting.
Conflicting studies suggest unresolved aspects of renal nephrometry [9-13], including: 1) 
determining the level of a reader's clinical expertise and training required for adequate score 
assignment; 2) choosing the most reliable and clinically relevant system among those 
available; and 3) identifying truly relevant biometric data to be reported. In an attempt to 
address these problems, we applied the R.E.N.A.L., the Preoperative Aspects and 
Dimensions Used for an Anatomical Classification System (PADUA), and the centrality 
index (C-Index) systems to patients undergoing either open, laparoscopic, or robot-assisted 
laparoscopic PN at Memorial Sloan Kettering Cancer Center (MSKCC); and evaluated the 
interobserver variability (IOV) among observers with varying degrees of clinical experience; 
each system's ability to predict surgical complexity and clinical outcomes; and the clinical 
relevance of nephrometry subscales.
Materials and Methods
Following Institutional Review Board approval, we retrospectively reviewed the records of 
90 patients with a renal mass who underwent computed tomography (CT) and PN at our 
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institution. The 30 most recent open, laparoscopic, and robot-assisted laparoscopic PN 
patients were selected backwards from January 2012. PN patients, whose CT were not 
performed at MSKCC using our institutional renal mass imaging protocol were excluded 
from the study.
All CT exams, performed using a 64-detector row CT scanner (General Electric Medical 
Systems, Pewaukee, WI, USA), consisted of non-contrast enhanced data acquisition from 
the top of the diaphragm to the lesser femoral trochanter, followed by contrast-enhanced 
data acquisitions during the nephrographic and excretory phases. Iodinated contrast agent 
(150 mL) was given at a constant flow rate of 3.5 mL/s via an antecubital vein. 
Nephrographic and excretory phase images were acquired after a 90-second and 3-minute 
delay, respectively. Transverse and coronal images were reconstructed at a slice thickness of 
2.5 mm and reconstruction increment of 2 mm from the nephrographic and excretory phase 
data.
CT images of renal masses were independently scored by 1 radiology fellow (RFEL); 3 
physicians (PHYS) including 2 urology fellows and 1 radiology resident; and 1 non-medical 
secondary school student (NMS) using the R.E.N.A.L. [2], PADUA [3], and C-Index 
systems [4]. Scores from the reader with the greatest clinical experience (RFEL) were used 
as reference standard.
Readers were blinded to other readers' results, patient demographics, surgical approach, and 
clinical outcomes. Intraclass correlation coefficient (ICC) was calculated to determine levels 
of agreement within each system among 1) all readers; 2) RFEL vs. PHYS; and 3) RFEL vs. 
NMS. Perfect agreement between the readers would result in ICC = 1, whereas ICC between 
0 and 1 would show disagreement. Confidence intervals for differences in ICC were 
estimated using bootstrap re-sampling. We calculated the proportion of instances in which 
the scores of the PHYS and the scores of the NMS differed from RFEL's scores by less than 
1, 2, 3, or 4 points. Since the three nephrometry scoring systems are not on the same scale, 
the proportion of matching scores was not used to compare the systems but instead to 
describe the readers' score consistency within each system.
To assess each system's ability to predict surgical complexity and postoperative outcomes, 
Spearman correlations were used to evaluate the relationship between RFEL scores and 
ischemia time and percent change in estimated glomerular filtration rate (eGFR) from 
baseline to postoperative 6 weeks (± 4 weeks) and 6 months (± 1 months). Clinically 
relevant components of the R.E.N.A.L. and PADUA systems were identified using 
Spearman correlations to evaluate the ability of RFEL scores on each of the R.E.N.A.L. and 
PADUA subscales to predict ischemia time and percent change in eGFR at the same 
intervals.
Correlations between maximum tumor diameter and tumor volume as continuous variables 
and outcomes of interest were also evaluated.
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Results
Baseline characteristics are presented in Table 1. On ICC analysis (Table 2A), the C-Index 
method always had the highest level of agreement amongst the readers (RFEL and PHYS 
and NMS), regardless of clinical experience. This level of agreement was significantly 
higher than with R.E.N.A.L. though not with PADUA systems (difference 0.113, 95% 
confidence interval [CI] 0.011, 0.171; and difference 0.096, 95% CI -0.003, 0.158, 
respectively). When looking at RFEL and NMS scores only, the level of agreement was also 
highest with the C-Index and lower with PADUA and R.E.N.A.L. systems. Similarly, when 
looking at RFEL and PHYS scores only, the level of agreement continued to be highest with 
the C-Index, although the level of agreement when using the R.E.N.A.L. system was slightly 
higher than with the PADUA system. Irrespective of the scoring system used, the agreement 
amongst the more clinically experienced PHYS and the RFEL was always higher than the 
agreement between the NMS and the RFEL. However, these increases in agreement were 
not significant on any of the scoring systems (95% CI for R.E.N.A.L: -0.076, 0.159; for 
PADUA: -0.116, 0.115; for C-Index: -0.147, 0.133).
The proportion of scores within different ranges of the RFEL was also analyzed (Table 2B). 
When using the R.E.N.A.L. and the PADUA systems, the NMS always agreed with the 
RFEL less often than the PHYS for all point ranges. However, when using the C-Index, the 
rates of agreement between the NMS and the RFEL were similar to those between the PHYS 
and the RFEL for all point ranges. The proportions of scores with perfect match between all 
readers and the RFEL by subscale are also shown in Table 2C.
On Spearman correlation, RFEL scores on all scoring systems were significantly associated 
with ischemia time (Table 3). Only RFEL scores using the C-Index were associated with 
percent change in postoperative eGFR at 6 weeks (p = 0.016). None of the RFEL scores on 
any of the scoring systems were associated with percent change in postoperative eGFR at 6 
months (all p > 0.05).
Spearman correlation between surgical outcomes and R.E.N.AL. and PADUA subscales was 
investigated to discern the most relevant aspects of these systems (Table 3). In the 
R.E.N.A.L. scoring system, showed a significant association between the subscales of tumor 
(R)adius, (N)earness to sinus, and (L)ocation relative to the polar lines and ischemia time. 
Using the PADUA system, tumor size, renal sinus involvement, and urinary collecting 
system involvement significantly (all p ≤0.0002) correlated with ischemia time.
On Spearman correlation, both maximum tumor size and tumor volume as continuous 
variables were significantly associated with ischemia time (Corr. = 0.45, p <0.0001 and 
Corr. = 0.44, p <0.0001, respectively), although no such association was found with percent 
change in postoperative eGFR at 6 weeks or 6 months (all p >0.05).
Discussion
Though some commonalities exist among the R.E.N.A.L. nephrometry scoring system [2], 
the PADUA classification system [3], and the C-Index method [4], each provides a unique 
score, using variables that cannot be transformed for cross compatibility. The assignment of 
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an appropriate score using any of these three systems relies on systematic and consistent 
reading and interpretation of CT findings. Okhunov et al. showed the highest ICC (0.92) 
using the R.E.N.A.L. system, followed by the C-Index (0.84) and the PADUA (0.81) 
systems. Correlation with length of warm ischemia time and percent change in creatinine 
level (all systems), and inverse correlation with length of stay (LOS) (C-Index) was also 
found [9]. Good concordance and kappa values amongst readers were also found in studies 
on IOV of the R.EN.A.L. system used for open or laparoscopic PN patients, respectively 
[14,15]. In these studies, however, scores were assigned by small groups of urologists at 
different stages of professional development but with similar urological training.
Our study shows that accuracy, interpretability, and reproducibility of different nephrometry 
scoring systems become problematic when scores are assigned by readers with different 
areas of expertise and levels of training, or no medical training whatsoever. Although 
differences in levels of agreement amongst readers with varying degrees of experience were 
not statistically significant, we found that more extensive clinical and radiologic training 
resulted in higher ICC and smaller differences from the reference standard (RFEL). 
However, despite agreement between RFEL and PHYS was greater than between RFEL and 
NMS, PHYS' scores differed from RFEL's scores by up to 4 points on R.E.N.A.L. and 
PADUA. Such variability in systems with an 8-point range like R.E.N.A.L. and PADUA 
may lead to inconsistent classification of renal masses. For instance, when R.E.N.A.L 
nephrometry sums (NS) are categorized into low- (NS: 4-6), moderate- (NS: 7-9), and high- 
(NS: 10-12) complexity lesions for risk stratification [6], the same lesion might be scored 6 
(low complexity) and 10 (high complexity) by different readers. For these reasons, based on 
the clear indication that reader experience - in addition to scoring system complexity - is a 
key factor in the fidelity of scoring outcomes, we strongly recommend standardized 
reporting for publications using nephrometry scores detailing reader experience level.
Before arbitrarily adopting one of the existing systems to score an entire database of PN 
cases both retrospectively and prospectively, we sought to determine whether any of the 
three nephrometry scoring systems studied should be preferentially utilized for practical and 
idealized characteristics (learning and ease of applicability; score consistency and 
reproducibility among readers; correlation of scores with surgical complexity and clinical 
outcomes). In our cohort of patients the mathematical model C-Index, which is a measure of 
tumor centrality, showed the highest level of agreement amongst readers and appeared to be 
the least prone to subjectivity of the three systems. Consistent with this finding and those of 
prior studies [9,14,15], the analysis of the IOV of each system's individual components 
showed that the (R)adius and the (A)nterior/posterior subscales of the R.E.N.A.L. system 
and tumor size in the PADUA system had the highest concordance rates amongst readers 
while the (L)ocation relative to polar lines (R.E.N.A.L.) and the estimated exophytic 
component (PADUA) had the lowest concordance rates. Increased variability and reduced 
reproducibility amongst readers was observed particularly in instances where tumor size and 
location, and the degree of rotation of the kidney in respect to its ideal coronal view reduced 
the readers' ability to identify anatomical landmarks needed for the determination of the 
tumor location relative to the polar and sinus lines in the R.E.N.A.L. and PADUA systems, 
respectively. Furthermore, the impact of all these factors on the point-based R.E.N.A.L. and 
PADUA scoring systems resulted in greater discordance amongst readers than that observed 
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using the C-Index, which is based on continuous measures. Nonetheless, a certain degree of 
approximation and variability was observed with the C-Index as well, in particular when an 
imaginary ellipse around the kidney periphery has to be drawn to define the mid-polar 
reference point, and the distance (x) between the central axial reference point and the tumor 
center. In our study, however, the least discordance among readers was associated with the 
C-Index.
We were also interested in assessing each nephrometry system's ability to predict clinical 
outcomes. Despite having the lowest IOV, C-Index ability to predict ischemia time and 
percent change in eGFR was not much higher than that of R.E.N.A.L. and PADUA. In our 
cohort, the low rate of adverse events such as postoperative hematoma and urinary fistula 
formation prevented us from performing an analysis to find correlations between any of the 
nephrometry systems and these complications. Of note, operative time, estimated blood loss, 
and LOS were not included in our analysis because inherently different in different PN 
approaches. All three nephrometry systems showed the ability to help predicting ischemia 
time. However, we found no evidence that any of the systems was associated with percent 
change in eGFR from baseline with the exception of C-index at 6 postoperative weeks. 
Among subscales, only tumor size, nearness to sinus, and location relative to polar lines 
(R.E.N.A.L.) and tumor size, renal sinus involvement and collecting system involvement 
(PADUA) were correlated with ischemia time. No significant correlations were found 
between any of the subscales and percent change in eGFR from baseline. Our results, 
corroborated by the heterogeneity of outcomes from other studies [9.10,11,12], suggest that 
some of the arbitrary components of nephrometry systems may be clinically insignificant, 
supporting the need for further refinement to identify reliable predictors of post-surgical 
outcomes such as renal function and complication risk.
Limitations of this study include the relatively small size of the cohort which may have been 
insufficient in detecting small differences between groups.
Conclusions
IOV in existing nephrometry systems is reduced by increasing radiological and clinical 
expertise of the reader. Consistently, measures of tumor size and distance to intrarenal 
structures were useful in predicting surgical complexity and clinically relevant outcomes. 
Other morphologic descriptors of renal lesions appeared irrelevant for such predictions and 
may potentially be eliminated.
C-index scoring had the best performance of the three nephrometry systems studied and 
could predict short-term postoperative renal function.
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Abbreviations
ASA American Society of Anesthesiologists
C-Index Centrality Index
CI Confidence Interval
CT Computed Tomography
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration
CT Computed Tomography
eGFR Estimated Glomerular Filtration Rate
ICC Intraclass Correlation Coefficient
IOV Interobserver Variability
IQR Interquartile Range
MSKCC Memorial Sloan Kettering Cancer Center
NMS Non-Medical Secondary School Student
NS Nephrometry Sum
PADUA Preoperative Aspects and Dimensions Used for an Anatomical Classification 
System
PHYS Physicians (Urology Fellows + Radiology Resident)
PN Partial Nephrectomy
R.E.N.A.L Radius, Exophytic/endophytic, Nearness, Anterior/posterior, Location
RFEL Radiology Fellow
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Table 1
Patient characteristics. (Data presented as medians with interquartile ranges in parentheses or number of 
instances with percentages in parentheses. R.E.N.A.L., PADUA, and C-Index scores as assigned by the 
radiology fellow).
Characteristic
Age at surgery, yr, median (IQR) 58 (50, 66)
Gender, male, no. (%) 50 (56%)
Body mass index, median (IQR) 30 (26, 39)
Preoperative eGFR (mL/min/1.73 m2), median (IQR) 81 (66, 94)
ASA score, no. (%)
 Class 1 3 (3%)
 Class 2 34 (38%)
 Class 3 51 (57%)
 Class 4 2 (2%)
Maximum tumor size, cm, median (IQR) 3 (2, 5)
Tumor volume, mL, median (IQR) 38 (12, 151)
Clinical Stage
 T1a 57 (63.5%)
 T1b 30 (33.5%)
 T2a 3 (3%)
R.E.N.A.L. score, points, median (IQR) 8 (7, 9)
PADUA score, points, median (IQR) 10 (8, 11)
C-Index, median (IQR) 3 (2, 4)
Abbreviations: R.E.N.A.L. = Radius, Exophytic/endophytic, Nearness, Anterior/posterior, Location; PADUA = preoperative aspects and 
dimensions used for an anatomical classification system; C-Index = Centrality Index; ASA = American Society of Anesthesiologists; eGFR = 
estimated glomerular filtration rate (CKD-EPI); UTI = urinary tract infection.
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Table 3
Spearman correlations for radiology fellow's scores on R.E.N.A.L., PADUA, and C-Index systems with 
ischemia time and percent change in postoperative estimated glomerular filtration rates at 6 week and 6 
months with p-values in parentheses.
Ischemia Time Postoperative eGFR % Change at 6 Weeks (N = 71)
Postoperative Egfr % Change at 6 
Months (N = 75)
R.E.N.A.L. 0.481 (<0.0001) -0.152 (0.2) -0.16 (0.2)
Radius 0.398 (0.0001) -0.154 (0.2) -0.129 (0.3)
Exophytic/Endophytic -0.0326 (0.8) 0.123 (0.3) -0.125 (0.3)
Nearness to Sinus 0.461 (<0.0001) -0.214 (0.072) -0.145 (0.2)
Anterior/Posterior -0.0514 (0.6) -0.122 (0.3) 0.129 (0.3)
Location Relative to Polar Line 0.351 (0.001) -0.115 (0.3) -0.0559 (0.6)
PADUA 0.431 (<0.0001) -0.168 (0.2) -0.146 (0.2)
Tumor Size 0.383 (0.0002) -0.154 (0.2) -0.132 (0.3)
Renal Rim 0.146 (0.2) -0.129 (0.3) 0.168 (0.15)
Renal Sinus 0.437 (<0.0001) -0.148 (0.2) -0.0955 (0.4)
Collecting System 0.467 (<0.0001) -0.172 (0.2) -0.119 (0.3)
Polar Location 0.0834 (0.4) -0.0875 (0.5) -0.136 (0.2)
Anterior/Posterior -0.0638 (0.6) -0.0772 (0.5) 0.172 (0.14)
Exophytic Rate -0.101 (0.3) 0.101 (0.4) -0.0693 (0.6)
C-Index -0.388 (0.0002) 0.284 (0.016) 0.182 (0.12)
Abbreviations: R.E.N.A.L. = Radius, Exophytic/endophytic, Nearness, Anterior/posterior, Location; PADUA = preoperative aspects and 
dimensions used for an anatomical classification system; C-Index = Centrality Index, eGFR = estimated glomerular filtration rate.
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